Clinical Trial Update: A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Enpatoran for cutaneous lupus manifestations with or without systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Systemic Lupus Erythematosus

Drugs mentioned

• Enpatoran (enpatoran)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus | Phase 3 | Status: RECRUITING